kabutan

TERUMO CORPORATION shares fall on voluntary recall of thoracic stent graft system

Mon Jun 1, 2026 2:50 pm JST Catalyst

TERUMO CORPORATION <4543> shares fell on June 1 after the company announced a voluntary recall of certain variants of its RelayPro thoracic stent graft system, triggering selling pressure. The recall is classified as Class I, a category applied when a product carries a risk of serious health hazards or death. The medical device is used for endovascular treatment of thoracic aortic diseases. Four cases were reported at overseas medical institutions where the delivery system failed to separate properly from the stent graft, preventing its removal from the body. Three of those cases resulted in death during or after surgery. Terumo had already notified domestic clients to suspend use of the affected variants on April 16, but has now decided to voluntarily recall 123 units across 18 facilities.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles